St. Luke Medical Technology, Inc. is developing the LUKE Cardiac Monitoring System, a first-in-class implantable cardiac
device for continuous ischemia and arrhythmia detection.

LUKE integrates multi-vector sensing, adaptive AI, and cloud-based oversight to enable earlier diagnosis and intervention
for cardiac events. With more than 18 million annual global cardiovascular deaths, St. Luke addresses the single greatest
unmet need in preventive medicine.
Key Differentiators
  • Full-Spectrum Detection
    Arrhythmia and ischemia via waveform-level ECG analysis.
  • Patented Multi-Vector Sensing
    Multi-angle capture reduces blind spots.
  • Adaptive AI Personalization
    A self-learning engine tailors alerts to each patient.
  • Validated Real-Time Alerts
    Triple-layered review (AI + history + technician) helps ensure accuracy.
  • 10-Year Longevity
    Wireless recharging and
    ultra-low-power design.
  • Minimally Invasive Implant
    Small, safe, outpatient procedure.

“From AFib to ischemia, one implant covers it all.”
Why LUKE?
A cardiac sentinel that detects arrhythmias and ischemia (including STEMI and NSTEMI) to enable earlier intervention.
Always on and always monitoring
Silent symptoms no longer go unnoticed
Clinician-reviewed AI diagnostics
Faster response = earlier interventions = better outcomes
More than a device — LUKE is peace of mind.
Empower your care team. Protect your future. Trust LUKE.
Important Disclaimers


• The LUKE Cardiac Monitoring System is an investigational device and has not been cleared or approved by the U.S. Food and Drug Administration(FDA).

• The system is not intended to replace emergency medical care. Patients experiencing symptoms such as chest pain, shortness of breath, dizziness, or fainting should seek immediate medical attention.

• Data analysis and alerts are intended to support, not replace, the judgment of qualified healthcare professionals.

• Performance and safety have not yet been established for widespread clinical use.

• Device notifications and data outputs are intended to support clinician decision-making, not to serve as a sole basis for diagnosis or therapyinitiation.

• Patients experiencing acute chest pain, syncope, or related symptoms should seek immediate emergency care independent of device alerts.


Offices
20 S Sarah St. ,
St. Louis, MO 63108

2900 Carskaddon Ave,
Suite 200, Toledo, OH 43606

(314) 502-9417
info@stlukemed.com
By registering, you agree to receive emails from Luke and its trusted partners. View our Terms and Privacy Policy.
Back to Top
© St.Luke - All Rights Reserved
Terms of use
Privacy